Dr. Kshitij Domadiya

Consultant - Medical Oncologist

Qualification

Experience

Awards & Recognition

Memberships

Research & Publications

  • Only 9 Weeks or Complete 12 Months of Adjuvant Trastuzumab in Indian Early-Stage Breast Cancer Patients: Is It a Practice-Changing Approach in a Resource-Constrained Setting?
    Journal: Cancer Research, Statistics, and Treatment, July 2020; 3(2): 401
  • Study of Efficacy and Tolerability of Paclitaxel and Carboplatin as a Concurrent Chemoradiation Sensitizer Regimen in Patients with Esophageal Cancer: A Prospective Observational Study from a Tertiary Centre in Northern India
    Journal: Journal of Clinical Oncology, 2020; 38(15_suppl)
    DOI: 10.1200/JCO.2020.38.15_suppl.e16526
  • Real-World Outcomes of Checkpoint Inhibitor Immunotherapy in Renal and Urothelial Cancers in a Tertiary Care Cancer Center in India
    Journal: International Journal of Molecular & Immuno Oncology, September 2019; 4(3): 63–66
  • Good Response to Erlotinib After Progression on Osimertinib: A Rare Case of Spatiotemporal T790M Heterogeneity in EGFR-Mutant Non-Small Cell Lung Cancer
    Journal: South Asian Journal of Cancer, October 2017; 6(4): 179
  • Clinical-Epidemiological Profile of Influenza A (H1N1) Cases at a Tertiary Care Institute of Western India
    Journal: Indian Journal of Applied Research, October 2015; 5(10)

Conference Presentations & Academic Contributions

  • ESMO Asia Congress, Singapore (2018)
    Poster Presentation: Retrospective Evaluation of PD-L1 Expression in Tumour Tissue of Lung Carcinoma Patients and Its Correlation with Clinical and Demographic Data
  • IBCC, Jaipur (2017)
    E-Poster Presentation: Clinico-Pathological Profile of Basal & Non-Basal Subtypes of Triple Negative Breast Cancer